A major metabolite of the vitamin D analogue 1 alpha-hydroxyvitamin D-2 in human liver cells in culture has been identified as 1 alpha,24(S)-dihydroxyvitamin D-2 [1 alpha,24(S)-(OH)(2)D-2]. 1 alpha-Hydroxyvitamin D-3 incubated with the same cells gives rise to predominantly 25- and 27-hydroxylated products. Our identification of 1 alpha 24(S)-dihydroxyvitamin D-2 is based on comparisons of the liver cell metabolite;with chemically synthesized 1 alpha,24(S)-(OH)(2)D-2 and 1 alpha,24(R)-(OH)(2)D-2 by using HPLC, GC and GC-MS techniques. The stereochemical orientation of the 24-hydroxyl group was inferred after X-ray-crystallographic analysis of the 24(R)-OH epimer. 1 alpha,24(S)-Dihydroxyvitamin D-2 binds strongly to the vitamin D receptor and is biologically active in growth hormone and chloramphenicol acetyltransferase reporter gene expression systems in vitro, but binds poorly to rat vitamin D-binding globulin, DBP. We suggest that this metabolite, 1 alpha,24(S)-(OH)(2)D-2, possesses the spectrum of biological properties to be useful as a drug in the treatment of psoriasis, metabolic bone disease and cancer.